🐜
|
Development and Application of Ultra-Performance Liquid Chromatography-TOF MS for Precision Large Scale Urinary Metabolic Phenotyping.
19 auth.
M. Lewis,
Jake T. M. Pearce,
K. Spagou,
M. Green,
A. Dona,
Ada H. Y. Yuen,
Mark David,
D. Berry,
Katie E. Chappell,
V. Horneffer-van der Sluis,
...
R. Shaw,
S. Lovestone,
P. Elliott,
J. Shockcor,
J. Lindon,
O. Cloarec,
Z. Takáts,
E. Holmes,
J. Nicholson
|
6 |
2016 |
6 🐜
|
🐜
|
Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry with Electrospray Ionization Quantification of Tryptophan Metabolites and Markers of Gut Health in Serum and Plasma—Application to Clinical and Epidemiology Cohorts
13 auth.
Luke Whiley,
Leanne C. Nye,
Isobelle Grant,
Nick Andreas,
Katie E. Chappell,
M. Sarafian,
R. Misra,
R. Plumb,
M. Lewis,
J. Nicholson,
...
E. Holmes,
J. Swann,
I. Wilson
|
6 |
2019 |
6 🐜
|
🐜
|
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
16 auth.
Luke Whiley,
Katie E. Chappell,
E. D'Hondt,
M. Lewis,
B. Jiménez,
S. Snowden,
H. Soininen,
I. Kloszewska,
P. Mecocci,
M. Tsolaki,
...
B. Vellas,
J. Swann,
Abdul Hye,
S. Lovestone,
C. Legido-Quigley,
E. Holmes
|
6 |
2021 |
6 🐜
|
🐜
|
A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK)
11 auth.
Sarir Sarmad,
M. Viant,
W. Dunn,
R. Goodacre,
I. Wilson,
Katie E. Chappell,
...
Julian L Griffin,
V. O’Donnell,
B. Naicker,
M. Lewis,
Toru Suzuki
|
4 |
2023 |
4 🐜
|
🐜
|
Improved quantitation of short-chain carboxylic acids in human biofluids using 3-nitrophenylhydrazine derivatization and liquid chromatography with tandem mass spectrometry (LC-MS/MS).
13 auth.
Maria Valdivia-Garcia,
Katie E. Chappell,
S. Camuzeaux,
L. Olmo-García,
Verena Horneffer van der Sluis,
S. Radhakrishnan,
Hannah Stephens,
S. Bouri,
L. M. de Campos Braz,
H. Williams,
...
M. Lewis,
G. Frost,
Jia V. Li
|
3 |
2022 |
3 🐜
|
🐜
|
An Open Platform for Large Scale LC-MS-Based Metabolomics
15 auth.
M. Lewis,
E. Chekmeneva,
S. Camuzeaux,
Caroline J. Sands,
Ada H. Y. Yuen,
Mark David,
Ash Salam,
Katie E. Chappell,
Benjamin W. Cooper,
Gordon A Haggart,
...
L. Maslen,
María Gómez-Romero,
V. Horneffer-van der Sluis,
Gonçalo D. S. Correia,
Z. Takáts
|
3 |
2022 |
3 🐜
|
🐜
|
A targeted ultra performance liquid chromatography - Tandem mass spectrometric assay for tyrosine and metabolites in urine and plasma: Application to the effects of antibiotics on mice.
11 auth.
Marine P. M. Letertre,
A. Myridakis,
Luke Whiley,
S. Camuzeaux,
M. Lewis,
Katie E. Chappell,
...
Annie Thaikkatil,
M. Dumas,
J. Nicholson,
J. Swann,
I. Wilson
|
3 |
2020 |
3 🐜
|
🐜
|
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
22 auth.
Luke Whiley,
Katie E. Chappell,
E. D'Hondt,
M. Lewis,
B. Jiménez,
S. Snowden,
H. Soininen,
I. Kloszewska,
P. Mecocci,
M. Tsolaki,
...
B. Vellas,
J. Swann,
Abdul Hye,
S. Lovestone,
C. Legido-Quigley,
E. Holmes,
H. Soininen,
I. Kloszewska,
P. Mecocci,
M. Tsolaki,
B. Vellas,
S. Lovestone
|
0 |
2021 |
0 🐜
|